Turning Point Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. TPTX has around 2.9M shares in the U.S. ETF market. The largest ETF holder of TPTX is the SPDR S&P Biotech ETF (XBI), with approximately 649.55K shares. Investors may also find of interest that the ETF with the largest allocation to TPTX stock is Defiance NASDAQ Junior Biotechnology ETF (IBBJ), with a portfolio weight of 1.13%. On average, U.S. ETFs allocate 0.20% of TPTX to their portfolios.
Additionally, TPTX is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with TPTX as a holding is the Virtus LifeSci Biotech Clinical Trials ETF (BBC), with a return of 55.60%.